시장보고서
상품코드
1944477

효소면역측정법 시장 : 제품 종류별, 검체별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Enzyme Immunoassay Market, By Product Type, By Specimen, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 321 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

효소면역측정법 시장 규모는 2024년에 178억 5,009만 달러로 평가되었으며, 2025년부터 2032년까지 CAGR 3.87%로 확대될 전망입니다.

효소면역측정법(EIA)은 항원-항체 반응의 높은 특이성을 활용하여 항원, 항체, 호르몬, 단백질, 약물 등의 특정 물질을 검출 및 정량하는 생화학 분석 기술입니다. 이 방법에서는 효소가 항체 또는 항원에 화학적으로 결합하여 신호 발생 장치로 작용합니다. 표적 분자가 해당 항체에 결합하면 부착된 효소가 첨가된 기질과의 반응을 촉매하여 측정 가능한 신호(일반적으로 색 변화, 형광 또는 발광)를 생성합니다.

효소면역측정법 시장 역학

만성질환 및 감염성 질환의 증가와 진단 인프라 확충이 시장 수요를 견인할 것으로 예상됩니다.

HIV, 간염, 결핵, 신종 바이러스 감염과 같은 감염성 질환의 발생률 증가는 효소면역측정법 시장의 성장을 견인하는 주요 요인입니다. 효소면역측정법은 높은 정확도, 강력한 특이성, 비용 효율적인 성능을 제공하기 때문에 조기 진단, 대규모 스크리닝, 확진 검사에 널리 사용되고 있습니다. 동시에 심혈관질환, 암, 자가면역질환, 당뇨병 등 만성질환의 유병률 증가로 인해 신뢰할 수 있고 효율적인 진단 솔루션에 대한 필요성이 더욱 커지고 있습니다. 효소면역측정법은 질병 특이적 바이오마커, 호르몬, 항체를 식별하는 데 필수적이며, 적시에 진단하고 질병 진행을 지속적으로 모니터링할 수 있습니다. 전 세계 의료 시스템이 예방 의료, 조기 발견 및 환자 결과 개선에 더 중점을 두면서 전 세계 병원, 임상 실험실 및 진단 센터에서 EIA 기반 진단 검사의 사용이 꾸준히 확대되고 있습니다.

개선된 ELISA 키트, 고도의 자동화, 다중 검사 기능, 보다 효율적인 효소 및 기질 개발 등 효소면역측정법 플랫폼의 지속적인 기술 발전은 시장 확대에 크게 기여하고 있습니다. 자동화 및 반자동 EIA 시스템은 검사 효율을 향상시키고, 인위적인 실수를 최소화하며, 높은 처리량 분석이 가능하기 때문에 현대의 임상 검사실에 특히 매력적입니다. 또한, 정부의 지원 정책과 민간 부문의 투자 증가에 힘입어 신흥 경제국의 의료 및 진단 인프라가 빠르게 발전함에 따라 첨단 진단 솔루션에 대한 접근성이 확대되고 있습니다. 의약품 연구, 백신 개발, 임상시험 활동에서 효소면역측정법의 적용 확대도 시장 수요를 촉진하고 있습니다. 기술 혁신과 인프라 성장과 함께 임상, 연구, 산업 분야를 막론하고 전 세계적으로 효소면역측정법의 보급이 가속화되고 있습니다.

효소면역측정법 시장 : 세분화 분석

세계 효소면역측정법 시장은 제품 유형, 시료, 용도, 최종사용자, 지역에 따라 세분화됩니다.

검체별로는 혈액, 소변, 타액, 타액, 기타 등 5가지 카테고리로 분류됩니다. 혈액이 검체 부문에서 주요 점유율을 차지하는 이유는 높은 진단 신뢰성과 광범위한 임상 적용 가능성 때문입니다. 혈액 기반 검체는 항원, 항체, 호르몬, 단백질 등의 바이오마커 농도가 높아 효소면역측정법이 우수한 민감도와 특이성을 발휘할 수 있습니다. 병원, 진단 실험실 및 연구소에서 혈액 검사를 광범위하게 사용하면서 이 부문의 매출 점유율을 더욱 높이고 있습니다.

이 시장은 용도에 따라 감염, 심장학, 종양학, 자가면역질환, 치료제 모니터링, 기타 등 6가지 카테고리로 나뉩니다. 감염병 분야는 전 세계적으로 지속적으로 높은 수준의 감염병 유병률과 발생률로 인해 2024년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. HIV/AIDS, B형 및 C형 간염, 결핵, 독감, 기타 바이러스 및 세균 감염과 같은 질병은 특히 인구 밀집 지역과 개발도상국에서 여전히 심각한 공중보건 문제로 남아 있습니다. 이러한 지속적인 질병 부담은 정확하고 신속하며 비용 효율적인 진단 방법에 대한 강력한 수요를 불러일으키고 있습니다.

효소면역측정법 시장 - 지역별 분석

전 세계적으로 효소면역측정법 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카로 나뉘어져 있습니다. 북미는 선진적인 검사실 인프라, 높은 의료비 지출, 자동화 면역측정 기술의 조기 도입, 주요 진단 기업의 강력한 입지를 바탕으로 효소면역측정법 시장의 대부분을 차지하고 있습니다. 그 뒤를 이어 유럽은 탄탄한 공공 의료 시스템, 광범위한 정기 검진 프로그램, 감염 및 만성질환의 조기 발견에 대한 관심 증가가 시장을 뒷받침하고 있습니다. 아시아태평양은 의료 서비스 접근성 확대, 질병 부담 증가, 조기 진단 검사에 대한 인식 개선, 특히 중국 및 인도와 같은 국가에서 정부 및 민간 기업의 검사실 인프라에 대한 대규모 투자에 힘입어 가장 빠르게 성장하는 시장입니다. 라틴아메리카는 의료 인프라의 지속적인 개선과 진단 검사량의 증가로 꾸준한 성장세를 보이고 있습니다.

목차

제1장 효소면역측정법 시장 개요

제2장 주요 요약

제3장 효소면역측정법의 주요 시장 동향

제4장 효소면역측정법 시장 : 산업 분석

제5장 효소면역측정법 시장 : 높아지는 지정학적 긴장의 영향

제6장 효소면역측정법 시장 구도

제7장 효소면역측정법 시장 : 제품 종류별

제8장 효소면역측정법 시장 : 검체별

제9장 효소면역측정법 시장 : 용도별

제10장 효소면역측정법 시장 : 최종사용자별

제11장 효소면역측정법 시장 : 지역별

제12장 주요 벤더 분석 : 효소면역측정법 산업

제13장 AnalystView의 전방위적 분석

KSM 26.03.13

Enzyme Immunoassay Market size was valued at USD 17,850.09 Million in 2024, expanding to a CAGR of 3.87% from 2025 to 2032.

Enzyme Immunoassay (EIA) is a biochemical analytical technique used to detect and quantify specific substances such as antigens, antibodies, hormones, proteins, or drugs by exploiting the high specificity of antigen antibody interactions. In this method, an enzyme is chemically linked to an antibody or antigen and acts as a signal generator. When the target molecule binds to its corresponding antibody, the attached enzyme catalyzes a reaction with an added substrate, producing a measurable signal, usually a color change, fluorescence, or luminescence.

Enzyme Immunoassay Market- Market Dynamics

Increasing prevalence of chronic, infectious diseases and expansion of diagnostic infrastructure are expected to propel market demand

The rising incidence of infectious diseases such as HIV, hepatitis, tuberculosis, and newly emerging viral infections is a key factor driving growth in the enzyme immunoassay market. Enzyme immunoassays are extensively used for early diagnosis, large-scale screening, and confirmatory testing because they offer high accuracy, strong specificity, and cost-effective performance. At the same time, the increasing prevalence of chronic diseases including cardiovascular diseases, cancer, autoimmune conditions, and diabetes has intensified the need for dependable and efficient diagnostic solutions. Enzyme immunoassays are essential for identifying disease-specific biomarkers, hormones, and antibodies, enabling timely diagnosis and continuous monitoring of disease progression. With healthcare systems worldwide placing greater emphasis on preventive care, early detection, and improved patient outcomes, the use of EIA-based diagnostic tests is steadily expanding across hospitals, clinical laboratories, and diagnostic centers across the globe.

Ongoing technological advancements in enzyme immunoassay platforms such as improved ELISA kits, greater automation, multiplex testing capabilities, and the development of more efficient enzymes and substrates, are significantly contributing to market expansion. Automated and semi-automated EIA systems enhance testing efficiency, minimize manual errors, and enable high-throughput analysis, making them especially appealing to modern clinical laboratories. In addition, the rapid development of healthcare and diagnostic infrastructure in emerging economies, driven by supportive government policies and increased private-sector investment, has broadened access to advanced diagnostic solutions. The expanding application of enzyme immunoassays in pharmaceutical research, vaccine development, and clinical trial activities is also boosting market demand. Collectively, technological innovation and infrastructure growth are accelerating the widespread adoption of enzyme immunoassays across clinical, research, and industrial settings worldwide.

Enzyme Immunoassay Market- Segmentation Analysis:

The Global Enzyme Immunoassay Market is segmented on the basis of Product Type, Specimen, Application, End User, and Region.

The market is divided into five categories based on Specimen: blood, urine, saliva, and others. Blood segment in the specimen is primarily held major share because of its high diagnostic reliability and broad clinical applicability. Blood-based samples provide higher concentrations of biomarkers such as antigens, antibodies, hormones, and proteins, enabling enzyme immunoassays to deliver superior sensitivity and specificity. The widespread use of blood tests in hospitals, diagnostic laboratories, and research settings further boosts this segment's revenue share.

The market is divided into six categories based on Application: infectious diseases, cardiology, oncology, autoimmune disorders, therapeutic drug monitoring, and others. The infectious diseases segment held the majority market share in 2024, driven by the consistently high prevalence and incidence of infectious diseases across the globe. Conditions such as HIV/AIDS, hepatitis B and C, tuberculosis, influenza, and other viral and bacterial infections continue to pose significant public health challenges, particularly in densely populated and developing regions. This sustained disease burden has created strong demand for accurate, rapid, and cost-effective diagnostic methods.

Enzyme Immunoassay Market- Geographical Insights

Across the globe, the Enzyme Immunoassay market is split in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America accounts for the substantial share of the enzyme immunoassay market, driven by its advanced laboratory infrastructure, substantial healthcare expenditure, early adoption of automated immunoassay technologies, and the strong presence of major diagnostic companies. Followed by Europe which is supported by robust public healthcare systems, widespread routine screening programs, and increasing emphasis on early detection of infectious and chronic diseases. The Asia Pacific region represents the fastest-growing market, propelled by expanding access to healthcare services, a rising burden of diseases, greater awareness of early diagnostic testing, and significant investments in laboratory infrastructure by both governments and private players, particularly in countries such as China and India. Latin America is experiencing steady growth due to ongoing improvements in healthcare infrastructure and increasing volumes of diagnostic testing.

Italy Enzyme Immunoassay Market- Key Insights

China stands out as a major country in the Asia Pacific region and rapidly expanding country-level market within the enzyme immunoassay (EIA) sector. Growth is largely fueled by its vast population, the rising incidence of infectious and chronic diseases, and a growing need for timely and accurate diagnostic solutions. Government-led efforts to enhance public healthcare systems, broaden disease screening initiatives, and upgrade laboratory infrastructure have significantly accelerated the uptake of enzyme immunoassays in hospitals and diagnostic centers. Additionally, the strong expansion of China's biotechnology and pharmaceutical industries has increased the use of EIAs in areas such as drug discovery, vaccine development, and clinical research. Greater awareness of preventive healthcare, along with increasing adoption of automated and high-throughput immunoassay technologies, continues to drive steady and long-term growth of the EIA market in China.

Enzyme Immunoassay Market- Competitive Landscape:

The enzyme immunoassay (EIA) market is characterized by intense competition, with a mix of global healthcare conglomerates and specialized diagnostic companies competing to strengthen their market positions. Leading players such as Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, bioMerieux SA, and QuidelOrtho maintain strong competitiveness through extensive product portfolios, advanced immunoassay platforms, and well-established global distribution networks. These companies focus heavily on continuous innovation, offering automated and high-throughput enzyme immunoassay systems that improve laboratory efficiency, accuracy, and turnaround times. Significant investments in research and development enable them to regularly introduce new and improved assay kits targeting infectious diseases, chronic conditions, and specialized diagnostic applications.

Recent Developments:

In 2025, Revvity Inc. introduced the IDS i20, a fully automated chemiluminescence immunoassay solution, empowering multi-specialty testing on a single system which enhance workflow efficiency for clinical labs.

In February 2025, VION Biosciences completed the acquisition of BioAssay Systems, a company known for its expertise in high-throughput enzyme immunoassay technologies. This strategic move enhanced VION's footprint in the diagnostics and life sciences tools.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENZYME IMMUNOASSAY MARKET KEY PLAYERS

  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Becton, Dickinson and Company
  • Sysmex Corporation
  • PerkinElmer (Revvity)
  • Agilent Technologies
  • Merck KGaA
  • DiaSorin S.p.A.
  • Randox Laboratories
  • VION Biosciences
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Reagents & Kits
  • Instruments
  • Software & Services

GLOBAL ENZYME IMMUNOASSAY MARKET, BY SPECIMEN- MARKET ANALYSIS, 2019-2032

  • Blood
  • Urine
  • Saliva
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Infectious diseases
  • Cardiology
  • Oncology
  • Autoimmune disorders
  • Therapeutic drug monitoring
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotech Companies
  • Academic Research
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Enzyme Immunoassay Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Enzyme Immunoassay Market Snippet by Product Type
    • 2.1.2. Enzyme Immunoassay Market Snippet by Specimen
    • 2.1.3. Enzyme Immunoassay Market Snippet by Application
    • 2.1.4. Enzyme Immunoassay Market Snippet by End User
    • 2.1.5. Enzyme Immunoassay Market Snippet by Country
    • 2.1.6. Enzyme Immunoassay Market Snippet by Region
  • 2.2. Competitive Insights

3. Enzyme Immunoassay Key Market Trends

  • 3.1. Enzyme Immunoassay Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Enzyme Immunoassay Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Enzyme Immunoassay Market Opportunities
  • 3.4. Enzyme Immunoassay Market Future Trends

4. Enzyme Immunoassay Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Enzyme Immunoassay Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Enzyme Immunoassay Market Landscape

  • 6.1. Enzyme Immunoassay Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Enzyme Immunoassay Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Reagents & Kits
    • 7.1.3. Instruments
    • 7.1.4. Software & Services

8. Enzyme Immunoassay Market - By Specimen

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Specimen, 2024 & 2032 (%)
    • 8.1.2. Blood
    • 8.1.3. Urine
    • 8.1.4. Saliva
    • 8.1.5. Others

9. Enzyme Immunoassay Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Infectious diseases
    • 9.1.3. Cardiology
    • 9.1.4. Oncology
    • 9.1.5. Autoimmune disorders
    • 9.1.6. Therapeutic drug monitoring
    • 9.1.7. Others

10. Enzyme Immunoassay Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Specimen, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Pharmaceutical & Biotech Companies
    • 10.1.5. Academic Research
    • 10.1.6. Others

11. Enzyme Immunoassay Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Enzyme Immunoassay Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Enzyme Immunoassay Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Enzyme Immunoassay Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Enzyme Immunoassay Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Enzyme Immunoassay Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Enzyme Immunoassay Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Siemens Healthineers
    • 12.2.2. Danaher Corporation
    • 12.2.3. Thermo Fisher Scientific
    • 12.2.4. F. Hoffmann-La Roche AG
    • 12.2.5. Abbott Laboratories
    • 12.2.6. Bio-Rad Laboratories
    • 12.2.7. bioMerieux SA
    • 12.2.8. QuidelOrtho Corporation
    • 12.2.9. Becton, Dickinson and Company
    • 12.2.10. Sysmex Corporation
    • 12.2.11. PerkinElmer (Revvity)
    • 12.2.12. Agilent Technologies
    • 12.2.13. Merck KGaA
    • 12.2.14. DiaSorin S.p.A.
    • 12.2.15. Randox Laboratories
    • 12.2.16. VION Biosciences
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제